Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Rheumatoid Arthritis

  Free Subscription


Articles published in Clin Exp Rheumatol

Retrieve available abstracts of 245 articles:
HTML format
Text format



Single Articles


    May 2018
  1. LIU R, Zhao P, Tan W, Zhang M, et al
    Cell therapies for refractory rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 May 8. pii: 12448.
    PubMed     Text format     Abstract available


  2. TEITSMA XM, Jacobs JWG, Concepcion AN, Petho-Schramm A, et al
    Explorative analyses of protein biomarkers in patients with early rheumatoid arthritis achieving sustained drug-free remission after treatment with tocilizumab- or methotrexate-based strategies: from transcriptomics to proteomics.
    Clin Exp Rheumatol. 2018 May 8. pii: 12447.
    PubMed     Text format     Abstract available


  3. GUDMANN NS, Junker P, Juhl P, Thudium CS, et al
    Type IV collagen metabolism is associated with disease activity, radiographic progression and response to tocilizumab in rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 May 8. pii: 12293.
    PubMed     Text format     Abstract available


    April 2018
  4. HACIOGLU A, Hatemi G, Esatoglu SN, Hamuryudan V, et al
    Tapering tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective study.
    Clin Exp Rheumatol. 2018 Apr 19. pii: 12594.
    PubMed     Text format    


  5. LEE JH, Kim GT, Kim YK, Lee SG, et al
    Cognitive function of patients with rheumatoid arthritis is associated with disease activity but not carotid atherosclerotic changes.
    Clin Exp Rheumatol. 2018 Apr 13. pii: 12306.
    PubMed     Text format     Abstract available


  6. JIAO Y, Ding H, Huang S, Liu Y, et al
    Bcl-XL and Mcl-1 upregulation by calreticulin promotes apoptosis resistance of fibroblast-like synoviocytes via activation of PI3K/Akt and STAT3 pathways in rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Apr 13. pii: 12378.
    PubMed     Text format     Abstract available


  7. KIM SK, Choe JY, Kwak SG, Bae J, et al
    Effect of tumour necrosis factor-alpha inhibitors on renal function in patients with rheumatoid arthritis from the KOBIO registry from 2012 to 2016.
    Clin Exp Rheumatol. 2018 Apr 13. pii: 12359.
    PubMed     Text format     Abstract available


  8. PIANTONI S, Regola F, Scarsi M, Tincani A, et al
    Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept.
    Clin Exp Rheumatol. 2018 Apr 13. pii: 12159.
    PubMed     Text format    


    March 2018
  9. YU C, Li M, Duan X, Fang Y, et al
    Chinese registry of rheumatoid arthritis (CREDIT): Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Mar 21. pii: 12256.
    PubMed     Text format     Abstract available


  10. PASCUAL-RAMOS V, Contreras-Yanez I, Valencia-Quinones KR, Romero-Diaz J, et al
    Rheumatoid arthritis patients achieved better quality of life than systemic lupus erythematosus patients at sustained remission.
    Clin Exp Rheumatol. 2018 Mar 21. pii: 12094.
    PubMed     Text format     Abstract available


  11. GALEAZZI M, Alten R, Chartier M, Elbez Y, et al
    Retention and clinical response to abatacept in patients with rheumatoid arthritis: an Italian perspective.
    Clin Exp Rheumatol. 2018 Mar 21. pii: 11733.
    PubMed     Text format    


  12. KUUSELA E, Kouri VP, Olkkonen J, Koivuniemi R, et al
    Serum Epstein-Barr virus DNA, detected by droplet digital PCR, correlates with disease activity in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Mar 20. pii: 12073.
    PubMed     Text format     Abstract available


  13. MENGATO D, Messori A
    Adalimumab biosimilar in rheumatoid arthritis: a total-evidence assessment to evaluate equivalence with the originator based on network meta-analysis.
    Clin Exp Rheumatol. 2018 Mar 20. pii: 11928.
    PubMed     Text format    


  14. COMBE B, Lula S, Boone C, Durez P, et al
    Effects of biologic disease-modifying anti-rheumatic drugs on the radiographic progression of rheumatoid arthritis: a systematic literature review.
    Clin Exp Rheumatol. 2018 Mar 20. pii: 11621.
    PubMed     Text format     Abstract available


  15. LUBRANO E, Mesina F, Caporali R
    Clinical remission in rheumatoid arthritis and psoriatic arthritis.
    Clin Exp Rheumatol. 2018 Mar 16. pii: 12069.
    PubMed     Text format     Abstract available


  16. OMETTO F, Fedeli U, Schievano E, Botsios C, et al
    Cause-specific mortality in a large population-based cohort of patients with rheumatoid arthritis in Italy.
    Clin Exp Rheumatol. 2018 Mar 2. pii: 12288.
    PubMed     Text format     Abstract available


  17. CALABRESI E, Petrelli F, Bonifacio AF, Puxeddu I, et al
    One year in review 2018: pathogenesis of rheumatoid arthritis.
    Clin Exp Rheumatol. 2018;36:175-184.
    PubMed     Text format     Abstract available


    February 2018
  18. TINAZZI I, McGonagle D, Zabotti A, Chessa D, et al
    Comprehensive evaluation of finger flexor tendon entheseal soft tissue and bone changes by ultrasound can differentiate psoriatic arthritis and rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Feb 28. pii: 12336.
    PubMed     Text format     Abstract available


  19. XIE W, Li J, Zhang X, Li G, et al
    Trends in the activity of rheumatoid arthritis as the consequence of treat-to-target strategy: eight-year data from 2009 to 2016.
    Clin Exp Rheumatol. 2018 Feb 28. pii: 12460.
    PubMed     Text format     Abstract available


  20. BRITSEMMER K, van Schaardenburg D, Boers M, De Cock D, et al
    Prevalence and validity of ACR/EULAR remission in four European early rheumatoid arthritis cohorts.
    Clin Exp Rheumatol. 2018 Feb 26. pii: 11331.
    PubMed     Text format     Abstract available


  21. WEN H, Liu Y, Li J, Wei D, et al
    Inhibitory effect and mechanism of 1,25-dihydroxy vitamin D3 on RANKL expression in fibroblast-like synoviocytes and osteoclast-like cell formation induced by IL-22 in rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Feb 15. pii: 12260.
    PubMed     Text format     Abstract available


  22. MERDLER-RABINOWICZ R, Hassidim A, Hellou R, Merdler I, et al
    Self-reported childhood maltreatment, lifelong traumatic events and mental disorders in American and Israeli rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2018 Feb 15. pii: 12131.
    PubMed     Text format     Abstract available


  23. MANFREDI A, Sebastiani M, Cassone G, Colaci M, et al
    Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series.
    Clin Exp Rheumatol. 2018 Feb 14. pii: 12161.
    PubMed     Text format    


  24. KASHYAP S, Kumar U, Pandey AK, Kanjilal M, et al
    Functional characterisation of ADP ribosylation factor-like protein 15 in rheumatoid arthritis synovial fibroblasts.
    Clin Exp Rheumatol. 2018 Feb 14. pii: 12163.
    PubMed     Text format     Abstract available


  25. HARAGUCHI A, Yamada H, Kondo M, Okazaki K, et al
    Serum IgG ACPA-IgM RF immune complexes were detected in rheumatoid arthritis patients positive for IgM ACPA.
    Clin Exp Rheumatol. 2018 Feb 14. pii: 12212.
    PubMed     Text format     Abstract available


  26. GUDMANN NS, Hirata S, Karsdal MA, Kubo S, et al
    Increased remodelling of interstitial collagens and basement membrane is suppressed by treatment in patients with rheumatoid arthritis: serological evaluation of a one-year prospective study of 149 Japanese patients.
    Clin Exp Rheumatol. 2018 Feb 14. pii: 11742.
    PubMed     Text format     Abstract available


    January 2018
  27. ARAKI Y, Aizaki Y, Sato K, Oda H, et al
    Altered gene expression profiles of histone lysine methyltransferases and demethylases in rheumatoid arthritis synovial fibroblasts.
    Clin Exp Rheumatol. 2018 Jan 31. pii: 11175.
    PubMed     Text format     Abstract available


  28. TSUKAMOTO M, Suzuki K, Seta N, Takeuchi T, et al
    Increased circulating CD14brightCD16+ intermediate monocytes are regulated by TNF-alpha and IL-6 axis in accordance with disease activity in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Jan 31. pii: 12165.
    PubMed     Text format     Abstract available


  29. JUHL P, Thudium CS, Gudmann NS, Karsdal MA, et al
    IL-6 receptor inhibition modulates type III collagen and C-reactive protein degradation in rheumatoid arthritis patients with an inadequate response to anti-tumour necrosis factor therapy: analysis of connective tissue turnover in the tocilizumab RADI
    Clin Exp Rheumatol. 2018 Jan 31. pii: 12085.
    PubMed     Text format     Abstract available


  30. BO M, Erre GL, Niegowska M, Piras M, et al
    Interferon regulatory factor 5 is a potential target of autoimmune response triggered by Epstein-barr virus and Mycobacterium avium subsp. paratuberculosis in rheumatoid arthritis: investigating a mechanism of molecular mimicry.
    Clin Exp Rheumatol. 2018 Jan 15. pii: 11919.
    PubMed     Text format     Abstract available


  31. IANNAZZO S, Benucci M, Favalli EG
    Tocilizumab after a first-line with anti-TNF in rheumatoid arthritis: a cost-consequence analysis in the Italian setting.
    Clin Exp Rheumatol. 2018 Jan 15. pii: 12043.
    PubMed     Text format     Abstract available


  32. FERRAZ-AMARO I, Lopez-Mejias R, Tejera-Segura B, de Vera-Gonzalez AM, et al
    Amylin in the insulin resistance of patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Jan 15. pii: 12060.
    PubMed     Text format     Abstract available


  33. LEI X, Li H, Zhan Y, Qu J, et al
    Predict rheumatoid arthritis conversion from undifferentiated arthritis with dynamic contrast-enhanced MRI and laboratory indexes.
    Clin Exp Rheumatol. 2018 Jan 15. pii: 12185.
    PubMed     Text format     Abstract available


  34. PAPALOPOULOS I, Fanouriakis A, Kougkas N, Flouri I, et al
    Liver safety of non-tumour necrosis factor inhibitors in rheumatic patients with past hepatitis B virus infection: an observational, controlled, long-term study.
    Clin Exp Rheumatol. 2018;36:102-109.
    PubMed     Text format     Abstract available


  35. ZANKER M, Becher G, Arbach O, Maurer M, et al
    Improved adalimumab dose decision with comprehensive diagnostics data.
    Clin Exp Rheumatol. 2018;36:136-139.
    PubMed     Text format     Abstract available


    December 2017
  36. GENERALI E, Carrara G, Selmi C, Verstappen SMM, et al
    Comparison of the risks of hospitalisation for cardiovascular events in patients with rheumatoid arthritis treated with tocilizumab and etanercept.
    Clin Exp Rheumatol. 2017 Dec 28. pii: 11415.
    PubMed     Text format     Abstract available


  37. PENG W, Liang X, Zhong Y, Zhou Y, et al
    Increased levels of serum histone H4 and activated protein C in patients with active rheumatoid arthritis.
    Clin Exp Rheumatol. 2017 Dec 27. pii: 12000.
    PubMed     Text format     Abstract available


  38. MERONI PL, Zavaglia D, Girmenia C
    Vaccinations in adults with rheumatoid arthritis in an era of new disease-modifying anti-rheumatic drugs.
    Clin Exp Rheumatol. 2017 Dec 15. pii: 12008.
    PubMed     Text format     Abstract available


  39. NEUBAUER AS, Minartz C, Herrmann KH, Baerwald CGO, et al
    Cost-effectiveness of early treatment of ACPA-positive rheumatoid arthritis patients with abatacept.
    Clin Exp Rheumatol. 2017 Dec 15. pii: 12057.
    PubMed     Text format     Abstract available


  40. TSENG HW, Lu LY, Lam HC, Tsai KW, et al
    The influence of disease-modifying anti-rheumatic drugs and corticosteroids on the association between rheumatoid arthritis and skin cancer: a nationwide retrospective case-control study in Taiwan.
    Clin Exp Rheumatol. 2017 Dec 15. pii: 11961.
    PubMed     Text format     Abstract available


  41. HIFINGER M, Ramiro S, Putrik P, van Eijk-Hustings Y, et al
    The eumusc.net standards of care for rheumatoid arthritis: importance and current implementation according to patients and healthcare providers in the Netherlands.
    Clin Exp Rheumatol. 2017 Dec 15. pii: 11705.
    PubMed     Text format     Abstract available


    November 2017
  42. GUNTER S, Robinson C, Woodiwiss AJ, Norton GR, et al
    Arterial wave reflection and subclinical atherosclerosis in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017 Nov 28. pii: 12022.
    PubMed     Text format     Abstract available


  43. MATHSSON ALM L, Fountain DL, Cadwell KK, Madrigal AM, et al
    The performance of anti-cyclic citrullinated peptide assays in diagnosing rheumatoid arthritis: a systematic review and meta-analysis.
    Clin Exp Rheumatol. 2017 Nov 28. pii: 11864.
    PubMed     Text format     Abstract available


  44. GALLI M, Antinori S, Atzeni F, Meroni L, et al
    Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2017 Nov 28. pii: 11430.
    PubMed     Text format     Abstract available


  45. LIU Y, Wu J, Shen G, Lei P, et al
    Diagnostic value of BiP or anti-BiP antibodies for rheumatoid arthritis: a meta-analysis.
    Clin Exp Rheumatol. 2017 Nov 28. pii: 11922.
    PubMed     Text format     Abstract available


  46. NAGAI T, Matsueda Y, Tomita T, Yoshikawa H, et al
    The expression of mRNA for peptidylarginine deiminase type 2 and type 4 in bone marrow CD34+ cells in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  47. THOMAS K, Flouri I, Repa A, Fragiadaki K, et al
    High 3-year golimumab survival in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: real world data from 328 patients.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  48. PAPAGORAS C, Chrysanthopoulou A, Mitsios A, Arampatzioglou A, et al
    Autophagy inhibition in adult-onset Still's disease: still more space for hydroxychloroquine?
    Clin Exp Rheumatol. 2017;35 Suppl 108:133-134.
    PubMed     Text format    


  49. AGMON-LEVIN N, Dagan A, Peri Y, Anaya JM, et al
    The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic.
    Clin Exp Rheumatol. 2017;35:929-935.
    PubMed     Text format     Abstract available


  50. ROUHI A, Hazlewood G, Shaheen AA, Swain MG, et al
    Prevalence and risk factors for liver fibrosis detected by transient elastography or shear wave elastography in inflammatory arthritis: a systematic review.
    Clin Exp Rheumatol. 2017;35:1029-1036.
    PubMed     Text format     Abstract available


  51. HOULDER EL, Millier MJ, Highton J, Gwynne-Jones D, et al
    Expression of the genes facilitating methotrexate action within subcutaneous rheumatoid nodules.
    Clin Exp Rheumatol. 2017;35:943-947.
    PubMed     Text format     Abstract available


  52. DONGES E, Staatz CE, Benham H, Kubler P, et al
    Patterns in use and costs of conventional and biologic disease-modifying anti-rheumatic drugs in Australia.
    Clin Exp Rheumatol. 2017;35:907-912.
    PubMed     Text format     Abstract available


    October 2017
  53. MA MHY, Ibrahim F, Kingsley GH, Cope A, et al
    Variable impacts of different remission states on health-related quality of life in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  54. POPE JE, Rampakakis E, Movahedi M, Cesta A, et al
    Treatment patterns in rheumatoid arthritis after discontinuation of methotrexate: data from the Ontario Best Practices Research Initiative (OBRI).
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  55. TWEEHUYSEN L, Schraa K, Netea MG, van den Hoogen FHJ, et al
    Ex-vivo inhibited cytokine profiling explains inferior treatment response to golimumab after adalimumab failure in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


    September 2017
  56. BURSKA AN, Neilan J, Chisman RE, Pitaksalee R, et al
    Serum IL-7 as diagnostic biomarker for rheumatoid arthritis, validation with EULAR 2010 classification criteria.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  57. FERRO F, Elefante E, Luciano N, Talarico R, et al
    One year in review 2017: novelties in the treatment of rheumatoid arthritis.
    Clin Exp Rheumatol. 2017;35:721-734.
    PubMed     Text format     Abstract available


  58. CHUA JR, Gibson KA, Pincus T
    Pain and other self-report scores in patients with osteoarthritis indicate generally similar disease burden to patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2017;35 Suppl 107:88-93.
    PubMed     Text format     Abstract available


  59. MCWILLIAMS DF, Walsh DA
    Pain mechanisms in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017;35 Suppl 107:94-101.
    PubMed     Text format     Abstract available


  60. BARTALESI F, Scire C, Requena-Mendez A, Abad MA, et al
    Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the
    Clin Exp Rheumatol. 2017;35:752-765.
    PubMed     Text format     Abstract available


  61. TANDON M, Perez P, Burbelo PD, Calkins C, et al
    Laser microdissection coupled with RNA-seq reveal cell-type and disease-specific markers in the salivary gland of Sjogren's syndrome patients.
    Clin Exp Rheumatol. 2017;35:777-785.
    PubMed     Text format     Abstract available


  62. CHUA JR, Castrejon I, Pincus T
    Assessment of pain and other patient symptoms in routine clinical care as quantitative, standardised, "scientific" data.
    Clin Exp Rheumatol. 2017;35 Suppl 107:13-20.
    PubMed     Text format     Abstract available


    August 2017
  63. SUN Y, Sun X, Liu Z, Wang X, et al
    MiR-338-5p suppresses rheumatoid arthritis synovial fibroblasts proliferation and invasion by targeting ADAMTS-9.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  64. SIEBUHR AS, Kjelgaard-Petersen CF, Sun S, Byrjalsen I, et al
    Suppression of active, but not total MMP-3, is associated with treatment response in a phase III clinical study of rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  65. MARTINEZ-ESTUPINAN L, Hernandez-Florez D, Janta I, Ovalles-Bonilla JG, et al
    An exploratory study to determine whether infliximab modifies levels of rheumatoid factor and antibodies to cyclic citrullinated peptides in rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  66. WEN W, Li Y, Cheng Y, He J, et al
    Lipopolysaccharide-binding protein is a sensitive disease activity biomarker for rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


    July 2017
  67. MANARA M, Caporali R, Favalli EG, Grosso V, et al
    Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  68. GIACOMELLI R, Ruscitti P, Bombardieri S, Cuomo G, et al
    What could we learn from the sub-analysis of a single nation cohort in a worldwide study? Lessons from the results observed in the Italian cohort of the GO-MORE trial.
    Clin Exp Rheumatol. 2017;35:623-629.
    PubMed     Text format     Abstract available


  69. PERTOVAARA M, Korpela M
    RAPID3 correlates with ESSPRI and other patient-reported outcomes in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2017;35:718.
    PubMed     Text format     Abstract available


  70. BUSTAMENTE L, Matthieu B, Marquette CH, Roux C, et al
    Sarcoidosis and tocilizumab: is there a link?
    Clin Exp Rheumatol. 2017;35:716.
    PubMed     Text format     Abstract available


  71. QUARTUCCIO L, Mavragani CP, Nezos A, Gandolfo S, et al
    Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjogren's syndrome.
    Clin Exp Rheumatol. 2017;35:719-720.
    PubMed     Text format     Abstract available


  72. SFIKAKIS PP, Bournia VK, Sidiropoulos P, Boumpas DT, et al
    Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.
    Clin Exp Rheumatol. 2017;35:579-585.
    PubMed     Text format     Abstract available


  73. SAIKI O, Uda H
    Successful extension of tocilizumab infusion intervals from 4 weeks to 6 or 5 weeks in 90% of RA patients with good response to 4-week intervals.
    Clin Exp Rheumatol. 2017;35:666-670.
    PubMed     Text format     Abstract available


    June 2017
  74. AYDIN SZ, Gunal EK, Ozata M, Keskin H, et al
    Six-joint ultrasound in rheumatoid arthritis: a feasible approach for implementing ultrasound in remission.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  75. LEON L, Gomez A, Vadillo C, Pato E, et al
    Severe adverse drug reactions to biological disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis in clinical practice.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  76. BELL DA, Elhayek S, Cairns E, Barra L, et al
    Anti-homocitrullinated protein antibody isotype usage in rheumatoid arthritis and their unaffected first-degree relatives.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  77. MARRIE RA, Hitchon CA, Peschken CA, Chen H, et al
    Health care utilisation before and after intensive care unit admission in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  78. MASI AT, Rehman AA, Jorgenson LC, Aldag JC, et al
    Preclinical biomarker associations with both incident rheumatoid arthritis and its subsequent mortality: sex effects in a 41-year, community-based, case-control cohort study.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  79. LESUIS N, van Vollenhoven RF, Akkermans RP, Verhoef LM, et al
    Rheumatologists' guideline adherence in rheumatoid arthritis: a randomised controlled study on electronic decision support, education and feedback.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


    May 2017
  80. HAMMER HB, Kvien TK, Terslev L
    Tenosynovitis in rheumatoid arthritis patients on biologic treatment: involvement and sensitivity to change compared to joint inflammation.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  81. DUQUENNE C, Wendling D, Sibilia J, Job-Deslandre C, et al
    Glucocorticoid-sparing effect of first-year anti-TNFalpha treatment in rheumatoid arthritis (CORPUS Cohort).
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  82. CAPORALI R, Idolazzi L, Bombardieri S, Ferraccioli G, et al
    Tocilizumab in the treatment of patients with rheumatoid arthritis in real clinical practice: results of an Italian observational study.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  83. SEBASTIANI M, Manfredi A, Cassone G, Sandri G, et al
    Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  84. ACEBES C, Andreu JL, Balsa A, Battle E, et al
    Exploring the remission concept in rheumatoid arthritis with patients and rheumatologists: time for a new approach?
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  85. CODULLO V, Iannone F, Sinigaglia L, Favalli EG, et al
    Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  86. GULLICK NJ, Mian AN, Ibrahim F, Walker D, et al
    Predicting responses in patients with rheumatoid arthritis to disease-modifying agents using baseline clinical data.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  87. RASHID T, Ebringer A, Wilson C
    The link between Proteus mirabilis, environmental factors and autoantibodies in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  88. GADEHOLT O
    Rheumatoid arthritis is not a single disease.
    Clin Exp Rheumatol. 2017;35 Suppl 104:20-21.
    PubMed     Text format     Abstract available


  89. ANGELOTTI F, Parma A, Cafaro G, Capecchi R, et al
    One year in review 2017: pathogenesis of rheumatoid arthritis.
    Clin Exp Rheumatol. 2017;35:368-378.
    PubMed     Text format     Abstract available


  90. DANDA D, Sharma R, Truong D, Koelsch KA, et al
    Anti-La positive, anti-Ro negative subset of primary Sjogren's syndrome: anti-La is a reality but is the disease?
    Clin Exp Rheumatol. 2017;35:438-444.
    PubMed     Text format     Abstract available


  91. QUARTUCCIO L, Baldini C, Bartoloni E, Priori R, et al
    Correlation between ESSDAI and ClinESSDAI in a real-life cohort of patients with Sjogren's syndrome.
    Clin Exp Rheumatol. 2017;35:546-547.
    PubMed     Text format     Abstract available


  92. BALDUZZI S, Scire CA, Sakellariou G, Benaglio F, et al
    In early inflammatory polyarthritis more intensive management according to the 2010 ACR/EULAR criteria leads to higher rates of clinical remission: comparison of two cohorts treated according to different treat-to-target protocols.
    Clin Exp Rheumatol. 2017;35:401-405.
    PubMed     Text format     Abstract available


  93. GHIGGIA A, Torta R, Tesio V, Di Tella M, et al
    Psychosomatic syndromes in fibromyalgia.
    Clin Exp Rheumatol. 2017;35 Suppl 105:106-111.
    PubMed     Text format     Abstract available


  94. BARTON JC, Bertoli LF, Barton JC, Acton RT, et al
    Fibromyalgia in 300 adult index patients with primary immunodeficiency.
    Clin Exp Rheumatol. 2017;35 Suppl 105:68-73.
    PubMed     Text format     Abstract available


  95. TORRENTE-SEGARRA V, Corominas H, Sanchez-Piedra C, Fernandez-Castro M, et al
    Fibromyalgia prevalence and associated factors in primary Sjogren's syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER).
    Clin Exp Rheumatol. 2017;35 Suppl 105:28-34.
    PubMed     Text format     Abstract available


    April 2017
  96. HARAOUI B, Casado G, Czirjak L, Taylor A, et al
    Patterns of tocilizumab use, effectiveness and safety in patients with rheumatoid arthritis: core data results from a set of multinational observational studies.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  97. FUKUYO S, Nakayamada S, Iwata S, Kubo S, et al
    Abatacept therapy reduces CD28+CXCR5+ follicular helper-like T cells in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


    March 2017
  98. TIEN YC, Yen HH, Chiu YM
    Incidence and clinical characteristics of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  99. KURIYA B, Schieir O, Lin D, Xiong J, et al
    Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  100. YANG M, Galebach PJ, Signorovitch JE, Garg V, et al
    Effectiveness and healthcare costs among stabilised rheumatoid arthritis patients with dose reduction of adalimumab or etanercept in real world.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  101. AVILA-RIBEIRO P, Brault Y, Dougados M, Gossec L, et al
    Psychometric properties of sleep and coping numeric rating scales in rheumatoid arthritis: a subanalysis of an etanercept trial.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  102. CAPORALI R, Carletto A, Conti F, D'Angelo S, et al
    Using a modified Delphi process to establish clinical consensus for the diagnosis, risk assessment and abatacept treatment in patients with aggressive rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  103. FERRO F, Marcucci E, Orlandi M, Baldini C, et al
    One year in review 2017: primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2017;35:179-191.
    PubMed     Text format     Abstract available


  104. PERTOVAARA M, Parkkila S, Korpela M
    Anti-carbonic anhydrase autoantibodies and serum beta-2 microglobulin correlate with the ClinESSDAI score in patients with Sjogren's syndrome.
    Clin Exp Rheumatol. 2017;35:351.
    PubMed     Text format     Abstract available


  105. ARENDS S, Meiners PM, Moerman RV, Kroese FG, et al
    Physical fatigue characterises patient experience of primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2017;35:255-261.
    PubMed     Text format     Abstract available


  106. HAACKE EA, van der Vegt B, Meiners PM, Vissink A, et al
    Abatacept treatment of patients with primary Sjogren's syndrome results in a decrease of germinal centres in salivary gland tissue.
    Clin Exp Rheumatol. 2017;35:317-320.
    PubMed     Text format     Abstract available


  107. LEE KE, Kang JH, Yim YR, Kim JE, et al
    Predictive significance of CCL21 and CXCL13 levels in the minor salivary glands of patients with Sjogren's syndrome.
    Clin Exp Rheumatol. 2017;35:234-240.
    PubMed     Text format     Abstract available


  108. GIUFFRA V, Minozzi S, Vitiello A, Fornaciari A, et al
    On the history of gout: paleopathological evidence from the Medici family of Florence.
    Clin Exp Rheumatol. 2017;35:321-326.
    PubMed     Text format     Abstract available


    February 2017
  109. CURTIS JR, Lee EB, Martin G, Mariette X, et al
    Analysis of non-melanoma skin cancer across the tofacitinib rheumatoid arthritis clinical programme.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  110. KIM HW, Kwon YJ, Park BW, Song JJ, et al
    Differential expressions of NOD-like receptors and their associations with inflammatory responses in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  111. GANDIGA PC, George MD, Baker JF
    Choice of second biologic in rheumatoid arthritis patients with inadequate response to initial anti-TNF.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  112. PERROT S, Peixoto M, Dieude P, Hachulla E, et al
    Patient phenotypes in fibromyalgia comorbid with systemic sclerosis or rheumatoid arthritis: influence of diagnostic and screening tests. Screening with the FiRST questionnaire, diagnosis with the ACR1990 and revised ACR 2010 criteria.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


    January 2017
  113. NIKIPHOROU E, Galloway J, van Riel P, Yazici Y, et al
    The spectrum of early rheumatoid arthritis practice across the globe: results from a multinational cross sectional survey.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  114. LENERT A, Fardo DW
    Detecting novel micro RNAs in rheumatoid arthritis with gene-based association testing.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  115. NAGAFUCHI Y, Shoda H, Sumitomo S, Nakachi S, et al
    Enhanced gut homing receptor expression of unswitched memory B cells in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  116. BAKER JF, Ostergaard M, Emery P, Baker DG, et al
    Development and validation of rheumatoid arthritis magnetic resonance imaging inflammation thresholds associated with lack of damage progression.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  117. ADDIMANDA O, Marino M, Farina I, Trevisani M, et al
    Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  118. LAMPROPOULOS CE, Orfanos P, Manoussakis MN, Tzioufas AG, et al
    Treat-to-target biologic therapy in patients with rheumatoid arthritis is more efficacious and safe compared to delayed initiation of biologics: a real-world study.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  119. AYDIN SZ, Pay S, Inanc N, Kamali S, et al
    Which joints and why do rheumatologists scan in rheumatoid arthritis by ultrasonography? A real life experience.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  120. AMANN J, Wessels AM, Breitenfeldt F, Huscher D, et al
    Quantifying cutaneous adverse effects of systemic glucocorticoids in patients with rheumatoid arthritis: a cross-sectional cohort study.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  121. L'AMI MJ, Kneepkens EL, Nurmohamed MT, Krieckaert CL, et al
    Long-term treatment response in rheumatoid arthritis patients starting adalimumab or etanercept with or without concomitant methotrexate.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  122. PARK SK, Lee MY, Jang EJ, Kim HL, et al
    A comparison of discontinuation rates of tofacitinib and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and Bayesian network meta-analysis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  123. KRUMBHOLZ G, Junker S, Meier FM, Rickert M, et al
    Response of human rheumatoid arthritis osteoblasts and osteoclasts to adiponectin.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  124. HU Y, Cui J, Sparks JA, Malspeis S, et al
    Circulating carotenoids and subsequent risk of rheumatoid arthritis in women.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  125. TOURNADRE A, Pereira B, Dubost JJ, Rincheval N, et al
    Management of dyslipidemia in high-risk patients with recent-onset rheumatoid arthritis: targets still not met despite specific recommendations. Results from the ESPOIR cohort during the first five years of follow-up.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  126. CURTIS JR, Schulze-Koops H, Takiya L, Mebus CA, et al
    Efficacy and safety of tofacitinib in older and younger patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


  127. NICAISE C, Weichselbaum L, Schandene L, Gangji V, et al
    Phagocyte-specific S100A8/A9 is upregulated in primary Sjogren's syndrome and triggers the secretion of pro-inflammatory cytokines in vitro.
    Clin Exp Rheumatol. 2017;35:129-136.
    PubMed     Text format     Abstract available


  128. BIRT JA, Tan Y, Mozaffarian N
    Sjogren's syndrome: managed care data from a large United States population highlight real-world health care burden and lack of treatment options.
    Clin Exp Rheumatol. 2017;35:98-107.
    PubMed     Text format     Abstract available


  129. ATZENI F, Gianturco L, Colombo C, Ricci C, et al
    Can speckle tracking echocardiography detect subclinical left ventricular dysfunction in patients with primary Sjogren's syndrome?
    Clin Exp Rheumatol. 2017;35:173.
    PubMed     Text format     Abstract available


    December 2016
  130. CALVO-ALEN J, Monteagudo I, Salvador G, Vazquez-Rodriguez TR, et al
    Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  131. KRAUSE C, Herborn G, Braun J, Rudolf H, et al
    Response to methotrexate predicts long-term mortality of patients with rheumatoid arthritis independent of the degree of response: results of a re-evaluation 30 years after baseline.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  132. CECCARELLI F, Massafra U, Perricone C, Idolazzi L, et al
    Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE).
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  133. MARTELLI-PALOMINO G, Paoliello-Paschoalato AB, Crispim JC, Rassi DM, et al
    DNA damage increase in peripheral neutrophils from patients with rheumatoid arthritis is associated with the disease activity and the presence of shared epitope.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  134. DETORAKIS EE, Magkanas E, Lasithiotaki I, Sidiropoulos P, et al
    Evolution of imaging findings, laboratory and functional parameters in rheumatoid arthritis patients after one year of treatment with anti-TNF-alpha agents.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  135. GIOLLO A, Viapiana O, Carletto A, Ortolani R, et al
    Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  136. URSINI F, D'Angelo S, Russo E, Arturi F, et al
    Serum complement C3 strongly correlates with whole-body insulin sensitivity in rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  137. MASI AT, Rehman AA, Jorgenson LC, Aldag JC, et al
    Increased mortality of incident rheumatoid arthritis (RA) versus matched non-RA control subjects: a community-based long-term prospective cohort study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  138. RODRIGUEZ-RODRIGUEZ L, Leon L, Ivorra-Cortes J, Gomez A, et al
    Treatment in rheumatoid arthritis and mortality risk in clinical practice: the role of biologic agents.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  139. GENTY M, Combe B, Kostine M, Ardouin E, et al
    Improvement of fatigue in patients with rheumatoid arthritis treated with biologics: relation with sleep disorders, depression and clinical efficacy. A prospective, multicentre study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  140. RAMIREZ J, Iniciarte-Mundo J, Cuervo A, Ruiz-Esquide V, et al
    Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  141. CUPPEN BV, Jacobs JW, Ter Borg EJ, Marijnissen AC, et al
    Necessity of TNF-alpha inhibitor discontinuation in rheumatoid arthritis is predicted by smoking and number of previously used biological DMARDs.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  142. BOUBOUCHAIROPOULOU N, Flouri I, Drosos AA, Boki K, et al
    Treatment with the first TNF inhibitor in rheumatoid arthritis patients in the Hellenic Registry of Biologic Therapies improves quality of life especially in young patients with better baseline functional status.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  143. CECCHETTI S, Tatar Z, Galan P, Pereira B, et al
    Prevalence of vitamin D deficiency in rheumatoid arthritis and association with disease activity and cardiovascular risk factors: data from the COMEDRA study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  144. HAMURYUDAN V, Direskeneli H, Ertenli I, Inanc M, et al
    Direct and indirect healthcare costs of rheumatoid arthritis patients in Turkey.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  145. FISHER BA, Donatien P, Filer A, Winlove CP, et al
    Decrease in articular hypoxia and synovial blood flow at early time points following infliximab and etanercept treatment in rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  146. JIANG M, Ren F, Zheng Y, Yan R, et al
    Efficacy and safety of down-titration versus continuation strategies of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis with low disease activity or in remission: a systematic review and meta-analysis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  147. BELLUCCI E, Terenzi R, La Paglia GM, Gentileschi S, et al
    One year in review 2016: pathogenesis of rheumatoid arthritis.
    Clin Exp Rheumatol. 2016;34:793-801.
    PubMed     Text format     Abstract available


  148. BERGSTRA SA, Machado PM, van den Berg R, Landewe RB, et al
    Ten years of METEOR (an international rheumatoid arthritis registry): development, research opportunities and future perspectives.
    Clin Exp Rheumatol. 2016;34 Suppl 101:87-90.
    PubMed     Text format     Abstract available


  149. HETLAND ML, Krogh NS, Horslev-Petersen K, Schiottz-Christensen B, et al
    Using an electronic platform interactively to improve treatment outcome in patients with rheumatoid arthritis: new developments from the DANBIO registry.
    Clin Exp Rheumatol. 2016;34 Suppl 101:75-78.
    PubMed     Text format     Abstract available


  150. JACOBS JW
    The Computer Assisted Management in Early Rheumatoid Arthritis programme tool used in the CAMERA-I and CAMERA-II studies.
    Clin Exp Rheumatol. 2016;34 Suppl 101:69-72.
    PubMed     Text format     Abstract available


  151. VAN RIEL PL, Renskers L
    The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritis.
    Clin Exp Rheumatol. 2016;34 Suppl 101:40-44.
    PubMed     Text format     Abstract available


  152. SCHEINBERG M
    Is Etanar a new biologic?
    Clin Exp Rheumatol. 2016;34:954.
    PubMed     Text format     Abstract available


  153. HILLEN MR, Moret FM, Giovannone B, Kruize AA, et al
    Size matters: decreased glandular levels of anti-inflammatory short thymic stromal lymphopoietin in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2016;34:959-960.
    PubMed     Text format     Abstract available


  154. LAZAROU I, Kelly S, Humby F, Di Cicco M, et al
    Ultrasound-guided synovial biopsy of the wrist does not alter subsequent clinical or ultrasound disease activity assessments: a prospective study for incorporation of imaging in clinical trials.
    Clin Exp Rheumatol. 2016;34:802-807.
    PubMed     Text format     Abstract available


  155. SOLFIETTI L, Binello GB, Stella S, Bazzan M, et al
    Thrombin generation assay: interactions between chronic inflammation and haemostasis in patients with autoimmune diseases.
    Clin Exp Rheumatol. 2016;34:925-928.
    PubMed     Text format     Abstract available


  156. PINCUS T
    Electronic eRAPID3 (Routine Assessment of Patient Index Data): opportunities and complexities.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


  157. RICHTER A, Meissner Y, Strangfeld A, Zink A, et al
    Primary and secondary patient data in contrast: the use of observational studies like RABBIT.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


  158. PINCUS T
    Electronic multidimensional health assessment questionnaire (eMDHAQ): past, present and future of a proposed single data management system for clinical care, research, quality improvement, and monitoring of long-term outcomes.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


  159. ALETAHA D, Becede M, Smolen JS
    Information technology concerning SDAI and CDAI.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


  160. HUO Y, Veldhuizen RD, van der Heijde DM, Besselink NJ, et al
    Automated joint space width quantification of hand and wrist joints: a proof of concept study.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


  161. LEEB BF, Brezinschek HP, Rintelen B
    RADAI-5 and electronic monitoring tools.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


  162. SONG ST, Kim JJ, Lee S, Kim HA, et al
    Efficacy of tocilizumab therapy in Korean patients with adult-onset Still's disease: a multicentre retrospective study of 22 cases.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


    August 2016
  163. LEVITSKY A, Wick MC, Mottonen T, Leirisalo-Repo M, et al
    Early treatment intensification induces favourable radiographic outcomes according to predicted versus observed radiographic progression in early rheumatoid arthritis: a subanalysis of the randomised FIN-RACo and NEO-RACo trials.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  164. KUBO S, Nakano K, Nakayamada S, Hirata S, et al
    Clinical, radiographic and functional efficacy of abatacept in routine care for rheumatoid arthritis patients: Abatacept Leading Trial for RA on Imaging Remission (ALTAIR) study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  165. FERRAZ-AMARO I, Lopez-Mejias R, Ubilla B, Genre F, et al
    Proprotein convertase subtilisin/kexin type 9 in rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  166. KUUSALO LA, Puolakka KT, Kautiainen H, Alasaarela EM, et al
    Intra-articular glucocorticoid injections should not be neglected in the remission targeted treatment of early rheumatoid arthritis: a post hoc analysis from the NEO-RACo trial.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  167. VAN DEN HOEK J, Roorda LD, Boshuizen HC, Tijhuis GJ, et al
    Trend in and predictors for cardiovascular mortality in patients with rheumatoid arthritis over a period of 15 years: a prospective cohort study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  168. YOSHIHARA H, Yoneoka D, Margalit A
    National trends and in-hospital outcomes in patients with rheumatoid arthritis undergoing elective atlantoaxial spinal fusion surgery.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  169. ASAMI Y, Ishiguro H, Ueda A, Nakajima H, et al
    First report of membranous nephropathy and systemic lupus erythematosus associated with abatacept in rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  170. VASSILOPOULOS D, Delicha EM, Settas L, Andrianakos A, et al
    Safety profile of repeated rituximab cycles in unselected rheumatoid arthritis patients: a long-term, prospective real-life study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  171. MILUTINOVIC S
    Reply to: Could this be the pioneering case of short-blanket syndrome? Filippou et al.
    Clin Exp Rheumatol. 2016;34:721.
    PubMed     Text format    


  172. FILIPPOU G, Bertoldi I, Frediani B
    Could this be the pioneering case of short-blanket syndrome? Comment on: Development of ultrasound enthesitis score to identify patients with enthesitis having spondyloarthritis: prospective, double-blinded, controlled study. Milutinovic et al. Clin E
    Clin Exp Rheumatol. 2016;34:721.
    PubMed     Text format    


  173. TYRSIN D, Chuvpilo S, Matskevich A, Nemenov D, et al
    From TGN1412 to TAB08: the return of CD28 superagonist therapy to clinical development for the treatment of rheumatoid arthritis.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


  174. AVCI AB, Feist E, Burmester GR
    Targeting GM-CSF in rheumatoid arthritis.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


  175. PALM O, Ueland T, Garen T, Michelsen AE, et al
    Endostatin is higher and associated with pulmonary involvement in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2016;34:690-3.
    PubMed     Text format     Abstract available


  176. VREJU FA, Filippucci E, Gutierrez M, Di Geso L, et al
    Subclinical ultrasound synovitis in a particular joint is associated with ultrasound evidence of bone erosions in that same joint in rheumatoid patients in clinical remission.
    Clin Exp Rheumatol. 2016;34:673-8.
    PubMed     Text format     Abstract available


  177. CAPALDO C, Carvajal Alegria G, Cornec D, Jousse-Joulin S, et al
    The active immunological profile in patients with primary Sjogren's syndrome is restricted to typically encountered autoantibodies.
    Clin Exp Rheumatol. 2016;34:722.
    PubMed     Text format    


  178. ASIKAINEN J, Nikiphorou E, Kaarela K, Lindqvist E, et al
    Is long-term radiographic joint damage different between men and women? Prospective longitudinal data analysis of four early RA cohorts with greater than 15 years follow-up.
    Clin Exp Rheumatol. 2016;34:641-5.
    PubMed     Text format     Abstract available


  179. LEE J, Koh JH, Kwok SK, Park SH, et al
    The EULAR Sjogren's Syndrome Patient-Reported Index is an independent determinant of health-related utility values of Korean patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2016;34:663-7.
    PubMed     Text format     Abstract available


  180. BARONE F, Colafrancesco S
    Sjogren's syndrome: from pathogenesis to novel therapeutic targets.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


    June 2016
  181. DETERT J, Dziurla R, Hoff P, Gaber T, et al
    Effects of treatment with etanercept versus methotrexate on sleep quality, fatigue and selected immune parameters in patients with active rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  182. FRITSCH-STORK RD, Silva-Cardoso SC, Groot Koerkamp MJ, Broen JC, et al
    Expression of ERAP2 and LST1 is increased before start of therapy in rheumatoid arthritis patients with good clinical response to glucocorticoids.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  183. CHE H, Combe B, Morel J, Cantagrel A, et al
    Performance of patient-reported outcomes in the assessment of rheumatoid arthritis disease activity:the experience of the ESPOIR cohort.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  184. KAWASHIRI SY, Nishino A, Suzuki T, Nakashima Y, et al
    Rapid improvement of Clinical Disease Activity Index (CDAI) at 3 months predicts a preferable CDAI outcome at 1 year in active rheumatoid arthritis patients treated with tocilizumab: results from an observational investigation of daily clinical practi
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  185. PLASENCIA C, Wolbink G, Krieckaert CL, Kneepkens EL, et al
    Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  186. RODRIGUEZ-RODRIGUEZ L, Leon L, Lamas JR, Gomez A, et al
    Dose down-titration of biological DMARDs in patients with rheumatoid arthritis over time and in daily clinical practice.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  187. AALTONEN KJ, Turunen JH, Sokka T, Puolakka K, et al
    A survey on the medication adherence to methotrexate among rheumatoid arthritis patients treated with self-administered biologic drugs.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  188. WANG T, Zheng XJ, Ji YL, Liang ZA, et al
    Tumour markers in rheumatoid arthritis-associated interstitial lung disease.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  189. BAGNATO GL, Fiorenza A, Cordova F, Roberts WN, et al
    Clinical, autoimmune, and psychiatric parameters correlate with sleep disturbance in patients with systemic sclerosis and rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  190. HOLDEN SE, Currie CJ, Lennon M, Reynolds AV, et al
    Cost of dose escalation in people with rheumatoid arthritis treated with TNF inhibitors across Europe.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  191. CALABRO A, Caterino AL, Elefante E, Valentini V, et al
    One year in review 2016: novelties in the treatment of rheumatoid arthritis.
    Clin Exp Rheumatol. 2016;34:357-72.
    PubMed     Text format     Abstract available


  192. PRIORI R, Minniti A, Antonazzo B, Fusconi M, et al
    Sleep quality in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2016;34:373-9.
    PubMed     Text format     Abstract available


  193. VASKO R, Streich JH, Blaschke S, Muller GA, et al
    Vimentin fragments are potential markers of rheumatoid synovial fibroblasts.
    Clin Exp Rheumatol. 2016;34:513-20.
    PubMed     Text format     Abstract available


  194. PERTOVAARA M, Korpela M
    Regular physical activity is associated with lower levels of ESSPRI and other favourable patient-reported outcomes in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2016;34:560.
    PubMed     Text format    


  195. ZABOTTI A, Salvin S, Quartuccio L, De Vita S, et al
    Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands.
    Clin Exp Rheumatol. 2016;34:459-65.
    PubMed     Text format     Abstract available


  196. SAKAIRI T, Hiromura K, Kaneko Y, Maeshima A, et al
    Histological findings in the spleen affected by adult-onset Still's disease: a report of three cases.
    Clin Exp Rheumatol. 2016;34:566-7.
    PubMed     Text format    


    April 2016
  197. RAYMOND AR, Brooksbank RL, Millen AM, Norton GR, et al
    Telomere length, endothelial activation and carotid atherosclerosis in black and white African patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  198. WALLENSTEIN GV, Kanik KS, Wilkinson B, Cohen S, et al
    Effects of the oral Janus kinase inhibitor tofacitinib on patient-reported outcomes in patients with active rheumatoid arthritis: results of two Phase 2 randomised controlled trials.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  199. KREMER JM, Blanco R, Halland AM, Brzosko M, et al
    Clinical efficacy and safety maintained up to 5 years in patients with rheumatoid arthritis treated with tocilizumab in a randomised trial.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  200. GUALTIEROTTI R, Ingegnoli F, Griffini S, Grovetti E, et al
    Prothrombotic biomarkers in patients with rheumatoid arthritis: the beneficial effect of IL-6 receptor blockade.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  201. GONZALEZ-FERNANDEZ ML, Valor L, Morales-Lozano R, Hernandez-Florez D, et al
    To what extent is foot pain related to biomechanical changes and ultrasound-detected abnormalities in rheumatoid arthritis?
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  202. HOLMSTROM M, Koivuniemi R, Korpi K, Kaasalainen T, et al
    Cardiac magnetic resonance imaging reveals frequent myocardial involvement and dysfunction in active rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  203. GENG Y, Han J, Deng X, Zhang Z, et al
    Deep clinical remission: an optimised target in the management of rheumatoid arthritis? Experience from an ultrasonography study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  204. YANG X, Wang M, Zhang X, Li X, et al
    Diagnostic accuracy of anti-RA33 antibody for rheumatoid arthritis: systematic review and meta-analysis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  205. LEE YH, Bae SC
    Vitamin D level in rheumatoid arthritis and its correlation with the disease activity: a meta-analysis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  206. MANARA M, Bianchi G, Bruschi E, Azzolini V, et al
    Adherence to current recommendations on the use of methotrexate in rheumatoid arthritis in Italy: results from the MARI study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  207. RONGEN-VAN DARTEL SA, Repping-Wuts H, Donders R, van Hoogmoed D, et al
    A multidimensional 'path analysis' model of factors explaining fatigue in rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  208. NUSSLEIN HG, Alten R, Galeazzi M, Lorenz HM, et al
    Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  209. HODGE JA, Kawabata TT, Krishnaswami S, Clark JD, et al
    The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  210. SARAUX A, Rouanet S, Flipo RM, Poncet JC, et al
    Glucocorticoid-sparing in patients suffering from rheumatoid arthritis and treated with tocilizumab: the SPARE-1 study.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  211. RUIZ-LARRANAGA O, Uribarri M, Alcaro MC, Escorza-Trevino S, et al
    Genetic variants associated with rheumatoid arthritis patients and serotypes in European populations.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  212. LOPALCO G, Vitale A, Iannone F, Cantarini L, et al
    Anakinra long-term efficacy and safety in the management of Schnitzler's syndrome and latent tuberculosis infection.
    Clin Exp Rheumatol. 2016;34:353.
    PubMed     Text format    


  213. CHOI BY, Oh HJ, Lee YJ, Song YW, et al
    Prevalence and clinical impact of fibromyalgia in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2016;34.
    PubMed     Text format     Abstract available


  214. FERRO F, Vagelli R, Bruni C, Cafaro G, et al
    One year in review 2016: Sjogren's syndrome.
    Clin Exp Rheumatol. 2016;34:161-71.
    PubMed     Text format     Abstract available


  215. GALICIA-HERNANDEZ G, Parra-Salcedo F, Ugarte-Martinez P, Contreras-Yanez I, et al
    Sustained moderate-to-high disease activity and higher Charlson score are predictors of incidental serious infection events in RA patients treated with conventional disease-modifying anti-rheumatic drugs: a cohort study in the treat-to-target era.
    Clin Exp Rheumatol. 2016;34:261-9.
    PubMed     Text format     Abstract available


  216. MAUERMANN M, Hochauf-Stange K, Kleymann A, Conrad K, et al
    Parvovirus infection in early arthritis.
    Clin Exp Rheumatol. 2016;34:207-13.
    PubMed     Text format     Abstract available


  217. QUARTUCCIO L, Salvin S, Corazza L, Gandolfo S, et al
    Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjogren's syndrome: follow-up after the end of the phase II open-label BELISS study.
    Clin Exp Rheumatol. 2016;34:311-4.
    PubMed     Text format     Abstract available


  218. YOKOGAWA N, Lieberman SM, Sherry DD, Vivino FB, et al
    Features of childhood Sjogren's syndrome in comparison to adult Sjogren's syndrome: considerations in establishing child-specific diagnostic criteria.
    Clin Exp Rheumatol. 2016;34:343-51.
    PubMed     Text format     Abstract available


    February 2016
  219. TEJERA-SEGURA B, de Vera-Gonzalez AM, Lopez-Mejias R, Gonzalez-Gay MA, et al
    Serum cathepsin S and cystatin C: relationship to subclinical carotid atherosclerosis in rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  220. SEBASTIANI M, Manfredi A, Cerri S, Della Casa G, et al
    Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  221. YOSHIHARA H, Yoneoka D, Margalit A, Zuckerman JD, et al
    Rheumatoid arthritis patients undergoing total hip and knee arthroplasty have better in-hospital outcomes compared with non-rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  222. BERTHELOT JM, Sibilia J
    Rampant infections of bone marrow stem cell niches as triggers for spondyloarthropathies and rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  223. RINALDI LA, Simoni D, Maresca M, Monaco V, et al
    Gait abnormalities in early rheumatoid arthritis with temporomandibular joint involvement.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  224. IANNONE F, Tampoia M, Giannini M, Lopalco G, et al
    Changes in anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes serum levels in patients with rheumatoid arthritis following treatment with different biological drugs.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  225. REMUZGO-MARTINEZ S, Genre F, Lopez-Mejias R, Ubilla B, et al
    Decreased expression of methylene tetrahydrofolate reductase (MTHFR) gene in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  226. SCOTT IC, Ibrahim F, Simpson G, Kowalczyk A, et al
    A randomised trial evaluating anakinra in early active rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  227. FRAGOULIS GE, Stamopoulos P, Barbatis C, Tzioufas AG, et al
    Panniculitis: an unusual presenting manifestation of rheumatoid arthritis.
    Clin Exp Rheumatol. 2016.
    PubMed     Text format     Abstract available


  228. NAREDO E, Iagnocco A
    One year in review: ultrasound in arthritis.
    Clin Exp Rheumatol. 2016;34:1-10.
    PubMed     Text format     Abstract available


  229. VALIM V, Gerdts E, Jonsson R, Ferreira GA, et al
    Atherosclerosis in Sjogren's syndrome: evidence, possible mechanisms and knowledge gaps.
    Clin Exp Rheumatol. 2016;34:133-42.
    PubMed     Text format     Abstract available


  230. GUGGINO G, Ciccia F, Raimondo S, Giardina G, et al
    Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2016;34:25-31.
    PubMed     Text format     Abstract available


    December 2015
  231. COLOMBO E, Scarsi M, Piantoni S, Tincani A, et al
    Serum levels of granzyme B decrease in patients with rheumatoid arthritis responding to abatacept.
    Clin Exp Rheumatol. 2015.
    PubMed     Text format     Abstract available


  232. VIZZARDI E, Bazzani C, Cavazzana I, Sciatti E, et al
    Prognostic value of diastolic dysfunction in asymptomatic rheumatoid arthritis patients without cardiovascular risk factors.
    Clin Exp Rheumatol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  233. COHEN SB, Koenig A, Wang L, Kwok K, et al
    Efficacy and safety of tofacitinib in US and non-US rheumatoid arthritis patients: pooled analyses of phase II and III.
    Clin Exp Rheumatol. 2015.
    PubMed     Text format     Abstract available


  234. ANECCHINO C, Fanizza C, Marino V, Romero M, et al
    Drug outcome survey to evaluate anti-TNF treatment in rheumatoid arthritis: an Italian observational study (the DOSE study).
    Clin Exp Rheumatol. 2015.
    PubMed     Text format     Abstract available


  235. INANC N, Ozen G, Direskeneli H
    Predictive value of ultrasonographic assessment of disease activity in response to tumor necrosis factor-alpha inhibitor treatment in rheumatoid arthritis: a prospective cohort study.
    Clin Exp Rheumatol. 2015.
    PubMed     Text format     Abstract available


  236. FEDELE AL, Alivernini S, Gremese E, Ferraccioli G, et al
    CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis.
    Clin Exp Rheumatol. 2015.
    PubMed     Text format     Abstract available


  237. BARBIERI F, Zampogna G, Camellino D, Paparo F, et al
    Ankylosis of the wrist bones in patients with rheumatoid arthritis: a study with extremity-dedicated MRI.
    Clin Exp Rheumatol. 2015.
    PubMed     Text format     Abstract available


  238. CHEUNG PP, Guo Y, Lahiri M
    Predominance of large joint active synovitis in Asian patients with established rheumatoid arthritis.
    Clin Exp Rheumatol. 2015.
    PubMed     Text format     Abstract available


  239. YANG X, Gao F, Liu Y
    Association of homocysteine with immunological-inflammatory and metabolic laboratory markers and factors in relation to hyperhomocysteinaemia in rheumatoid arthritis.
    Clin Exp Rheumatol. 2015;33:900-3.
    PubMed     Text format     Abstract available


  240. IDOLAZZI L, Adami S, Capozza R, Bianchi G, et al
    Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study.
    Clin Exp Rheumatol. 2015;33:895-9.
    PubMed     Text format     Abstract available


  241. MILUTINOVIC S, Radunovic G, Veljkovic K, Zlatanovic M, et al
    Development of ultrasound enthesitis score to identify patients with enthesitis having spondyloarthritis: prospective, double-blinded, controlled study.
    Clin Exp Rheumatol. 2015;33:812-7.
    PubMed     Text format     Abstract available


  242. BALCI MA, Pamuk ON, Pamuk GE, Uzundere FK, et al
    Epidemiology and outcome of adult-onset Still's disease in Northwestern Thrace region in Turkey.
    Clin Exp Rheumatol. 2015;33:818-23.
    PubMed     Text format     Abstract available


  243. CHEN SY, Shiau AL, Wu CL, Wang CR, et al
    Amelioration of experimental arthritis by intra-articular injection of an epidermal growth factor receptor tyrosine kinase inhibitor.
    Clin Exp Rheumatol. 2015;33:839-43.
    PubMed     Text format     Abstract available


    September 2015
  244. ATISHA-FREGOSO Y, Rivera-Vicencio Y, Banos-Pelaez M, Hernandez-Molina G, et al
    Main causes and risk factors for hospitalisation in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2015;33:721-5.
    PubMed     Text format     Abstract available


  245. UNGPRASERT P, Srivali N, Kittanamongkolchai W
    Risk of venous thromboembolism in patients with Sjogren's syndrome: a systematic review and meta-analysis.
    Clin Exp Rheumatol. 2015;33:746-50.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: